News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement
|Articles|December 18, 2014

Pharm Exec eMedia Rate Card

Advertisement

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Stock.adobe.com weight loss cost

U.S. Prescription Drug Spending Set to Exceed $1 Trillion in 2026: Report

ByNicholas Jacobus
April 30th 2026
Stock.adobe.com new CEO

Sanofi Officially Appoints Belén Garijo as Chief Executive Officer Following Shareholder Vote

ByNicholas Jacobus
April 30th 2026
RNA is not just another modality; it is a programmable approach to drug development. Credit: Stock.Adobe.com/xyz+

BMS vs. Moderna vs. Pfizer: The RNA Platform Race

ByThani Jambulingam, PhD
April 30th 2026
Jessica Lovett

Asembia ASX26: Strategies for Building Relationships with Pharma Manufacturers

ByMike Hollan,Jessica Lovett
April 30th 2026
Jeff Golfman Send 123

How Teams Should Quantify and Prepare for Potential Cost Ripple Effects

ByNicholas Jacobus,Jeff Golfman
April 30th 2026
Advertisement
Advertisement

Trending on PharmExec

1

Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?

2

Teva Enters $900 Million Agreement to Acquire Emalex

3

Pharmaceutical Risks in the Strait of Hormuz

4

Rocket Pharmaceuticals Enters $180 Definitive Agreement to Sell its Priority Review Voucher

5

How are US Regulatory Actions Impacting Pricing?

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us